External validation of models for predicting risk of colorectal cancer using the China Kadoorie Biobank

[1]  D. Sussman,et al.  US Preventive Services Task Force Recommendation Statement on Screening for Colorectal Cancer. , 2021, JAMA.

[2]  Wanqing Chen,et al.  Cancer screening in China: The current status, challenges, and suggestions. , 2021, Cancer letters.

[3]  E. Riboli,et al.  Development and validation of a lifestyle-based model for colorectal cancer risk prediction: the LiFeCRC score , 2021, BMC Medicine.

[4]  D. Ransohoff,et al.  Derivation and validation of a predictive model for advanced colorectal neoplasia in asymptomatic adults , 2020, Gut.

[5]  S. Griffin,et al.  Risk Prediction Models for Kidney Cancer: A Systematic Review , 2020, European urology focus.

[6]  H. Brenner,et al.  Comparative Evaluation of Participation and Diagnostic Yield of Colonoscopy vs Fecal Immunochemical Test vs Risk-Adapted Screening in Colorectal Cancer Screening: Interim Analysis of a Multicenter Randomized Controlled Trial (TARGET-C). , 2020, The American journal of gastroenterology.

[7]  J. Emery,et al.  External Validation of Risk Prediction Models Incorporating Common Genetic Variants for Incident Colorectal Cancer Using UK Biobank , 2020, Cancer Prevention Research.

[8]  Zhengming Chen,et al.  Problem drinking, wellbeing and mortality risk in Chinese men: findings from the China Kadoorie Biobank , 2020, Addiction.

[9]  Jie He,et al.  Development of a risk score for colorectal cancer in Chinese males: A prospective cohort study , 2019, Cancer medicine.

[10]  J. Emery,et al.  Risk Prediction Models for Colorectal Cancer Incorporating Common Genetic Variants: A Systematic Review , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[11]  Hongbing Shen,et al.  Cancer incidence in relation to body fatness among 0.5 million men and women: Findings from the China Kadoorie Biobank , 2019, International journal of cancer.

[12]  Ni Li,et al.  Comparative evaluation of novel screening strategies for colorectal cancer screening in China (TARGET-C): a study protocol for a multicentre randomised controlled trial , 2019, BMJ Open.

[13]  Jie He,et al.  Participation and yield of a population-based colorectal cancer screening programme in China , 2018, Gut.

[14]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[15]  J. Emery,et al.  External validation of risk prediction models for incident colorectal cancer using UK Biobank , 2018, British Journal of Cancer.

[16]  Sin-Ho Jung,et al.  A prediction model for advanced colorectal neoplasia in an asymptomatic screening population , 2017, PloS one.

[17]  D. Bennett,et al.  Fruit consumption and physical activity in relation to all-cause and cardiovascular mortality among 70,000 Chinese adults with pre-existing vascular disease , 2017, PloS one.

[18]  M. Bishop,et al.  Genomics in routine clinical care: what does this mean for primary care? , 2017, The British journal of general practice : the journal of the Royal College of General Practitioners.

[19]  K. Humphreys,et al.  Governmental standard drink definitions and low-risk alcohol consumption guidelines in 37 countries. , 2016, Addiction.

[20]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[21]  Youming Li,et al.  Epidemiological Trends in Colorectal Cancer in China: An Ecological Study , 2016, Digestive Diseases and Sciences.

[22]  Aung Ko Win,et al.  Risk Prediction Models for Colorectal Cancer: A Systematic Review , 2015, Cancer Prevention Research.

[23]  D. Ransohoff,et al.  Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study , 2015 .

[24]  G. Collins,et al.  Effect of Ebola Progression in Liberia , 2015, Annals of Internal Medicine.

[25]  Jung Eun Lee,et al.  Sex- and gender-specific disparities in colorectal cancer risk. , 2015, World journal of gastroenterology.

[26]  Jon Emery,et al.  Risk Prediction Models for Melanoma: A Systematic Review , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[27]  Boneng Mao,et al.  Prediction rule for estimating advanced colorectal neoplasm risk in average-risk populations in southern Jiangsu Province. , 2014, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[28]  N. Cho,et al.  Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location , 2013, British Journal of Cancer.

[29]  Alan D. Lopez,et al.  Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet.

[30]  R. Collins,et al.  Alcohol consumption in 0.5 million people from 10 diverse regions of China: prevalence, patterns and socio-demographic and health-related correlates , 2013, International journal of epidemiology.

[31]  P. Elliott,et al.  UK Biobank: Current status and what it means for epidemiology , 2012 .

[32]  P. Jess,et al.  Possible better long-term survival in left versus right-sided colon cancer - a systematic review. , 2012, Danish medical journal.

[33]  E. Giovannucci,et al.  The effect of estrogen vs. combined estrogen‐progestogen therapy on the risk of colorectal cancer , 2012, International journal of cancer.

[34]  C. von Wagner,et al.  Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests , 2010, Gut.

[35]  R. Collins,et al.  China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. , 2011, International journal of epidemiology.

[36]  M. Inoue,et al.  10-Year risk of colorectal cancer: development and validation of a prediction model in middle-aged Japanese men. , 2010, Cancer epidemiology.

[37]  D. Evans,et al.  Assessing women at high risk of breast cancer: a review of risk assessment models. , 2010, Journal of the National Cancer Institute.

[38]  U. Jaisamrarn,et al.  The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function. , 2010, Maturitas.

[39]  Garrett Fitzmaurice,et al.  Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort , 2008, The Lancet.

[40]  J. Buring,et al.  Development of a risk score for colorectal cancer in men. , 2007, The American journal of medicine.

[41]  P Glasziou,et al.  Screening for colorectal cancer using the faecal occult blood test, Hemoccult. , 2007, The Cochrane database of systematic reviews.

[42]  E. Steingrímsson,et al.  Familial risk of colon and rectal cancer in Iceland: Evidence for different etiologic factors? , 2006, International Journal of Cancer.

[43]  M. Muñoz-Navas,et al.  Use of colonoscopy as a primary screening test for colorectal cancer in average risk people , 2003, American Journal of Gastroenterology.

[44]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[45]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.